Mastery EAQ Ch. 30

A  Corticotropin

B  Desmopressin

C  Somatropin

D  Octreotide

A  Octreotide

B  Somatropin

C  Desmopressin

D  Vasopressin

A  “If it is almost time for your next dose, take a double dose of the drug at that time.”

B  “You can take the dose immediately when you remember it.”

C  “You should consult your primary health care provider immediately.”

D  “Skip the missed dose and resume your usual dosage schedule.”

A  Cosyntropin

B  Vasopressin

C  Desmopressin

D  Somatropin

A  Drowsiness

B  Bleeding gums

C  Abdominal stress

D  Vertigo

A  “Heat the medicine before administration.”

B  “Shake the medication before administration.”

C  “Do not administer the drug to the patient.”

D  “Keep the bottle in warm water before administration.”

A  Monitor fluid status.

B  Monitor blood glucose levels closely.

C  Evaluate the patient for limping.

D  Encourage vigorous exercise.

A  Obtaining liver and renal function tests

B  Co-administering carbamazepine

C  Monitoring the patient in an intensive care unit

D  Administering the vasopressin intravenously

A  Bleeding gums

B  Excessive thirst

C  Limping

D  Abdominal cramps

A  Headache, Low urine output, Low blood pressure, Nausea

B  Nausea, Blood glucose elevation, Headache, Low urine output

C  Nausea, Blood glucose elevation, Headache, Low blood pressure

D  Low blood pressure, Blood glucose elevation, Headache, Low urine output

A  Somatropin intramuscular

B  Octreotide subcutaneous

C  Vasopressin nasal spray

D  Desmopressin intravenously

A  Electrocardiogram (ECG)

B  Renal panel

C  Liver enzymes

D  Blood glucose

A  Previous somatropin injection site tender to touch.

B  Radiology report identifies no fracture with closed growth plates.

C  Growth percentile has increased from the previous annual physical.

D  Reports episodic muscle pain during the past year.

A  Calculate the dosage with the pharmacist or another nurse

B  Obtain baseline weight and height measurements

C  Review current laboratory values for blood glucose

D  Review the frequency with the health care provider

A  Notice increase in body temperature

B  Inquire about abdominal discomfort

C  Assess the patient for headaches

D  Monitor for signs of infiltration

A  Elevated blood pressure, Weight gain

B  Edema of the extremities, Elevated blood pressure

C  Weight gain, Edema of the extremities

D  Increased urination, Thirst

A  Assess for signs of dehydration.

B  Make a note of the fluid intake.

C  Watch the IV site closely for infiltration.

D  Measure the patient’s urine output regularly.

A  Carcinoid tumor-secreting vasoactive intestinal peptide (VIP)

B  Small-bowel fistula and having an acute asthma attack

C  Esophageal varices and a history of type 2 diabetes

D  Acromegaly and a serum creatinine level of 5.0 mg/dL

A  1. Clear the nasal passages.
2. Prime the pump by pressing down four times.
3. Place the spray nozzle in the nostril.
4. Replace the cap on the bottle.
5. Give half a spray in each nostril.
6. Monitor the level of drug left in the pump.

B  1. Clear the nasal passages.
2. Prime the pump by pressing down four times.
3. Place the spray nozzle in the nostril.
4. Give half a spray in each nostril.
5. Replace the cap on the bottle.
6. Monitor the level of drug left in the pump.

C  1. Clear the nasal passages.
2. Prime the pump by pressing down four times.
3. Place the spray nozzle in the nostril.
4. Give half a spray in each nostril.
5. Monitor the level of drug left in the pump.
6. Replace the cap on the bottle.

D  1. Clear the nasal passages.
2. Give half a spray in each nostril.
3. Place the spray nozzle in the nostril.
4. Prime the pump by pressing down four times.
5. Replace the cap on the bottle.
6. Monitor the level of drug left in the pump.

A  Patient A: esophageal varices; type 1 diabetes

B  Patient D: VIP; severe diarrhea and flushing; renal impairment

C  Patient C: VIP; life-threatening hypotension; diarrhea and flushing

D  Patient B: carcinoid tumor; taking ciprofloxacin

A  Diarrhea, Flushing

B  Fatigue, Headache

C  Headache, Joint pain

D  Joint pain, Fatigue

A  The patient is stable and needs reassurance.

B  The medication is not effective for this condition.

C  A higher dose of medication is required for treatment.

D  The patient needs to adjust fluid intake.

A  Administering half the dose in each nostril

B  Inhaling the medication into the airway

C  Storing the pump at room temperature

D  Priming the pump each week

A  “Do you feel very thirsty lately?”
“How many times do you urinate in a day?”

B  “Do you have excessive bleeding due to minor injuries?”
“Is there any change in the color of your urine?”

C  “Is there any change in the color of your sputum?”
“Do you have excessive bleeding due to minor injuries?”

D  “Is there any change in the color of your urine?”
“Is there any change in the color of your sputum?”

A  Motor skills, Visual acuity, Skin turgor

B  Height, Weight, Motor skills

C  Skin turgor, Height, Visual acuity

D  Weight, Skin turgor, Visual acuity

A  Pressing the pump once to spray a 10-mcg dose

B  Priming the nasal pump once a week

C  Replacing the cap on the pump after the procedure

D  Pressing down on the pump two times to prime it

A  Hyperglycemia

B  Hypothyroidism

C  Hypercalciuria

D  Hypertension

A  “Inhale the drug preparation by spraying into the nostrils.”

B  “Apply the drug preparation topically to the nasal membranes.”

C  “Shake the drug preparation thoroughly before use.”

D  “Dilute the drug preparation before administration.”

A  Abundant, diluted urine

B  Loss of consciousness

C  Watery diarrhea

D  Oozing blood

A  Bilateral metastatic breast cancer

B  Acute bronchitis with laryngitis

C  Cachexia and closed growth plates

D  Human immunodeficiency virus (HIV) infection

A  A 7-year-old diagnosed with growth hormone deficiency

B  An 8-year-old with a pituitary tumor

C  A 17-year-old who is 5 feet tall

D  A 10-year-old of short stature who has severe asthma

A  Desmopressin and carbamazepine

B  Somatropin and glucocorticoids

C  Vasopressin and demeclocycline

D  Vasopressin and carbamazepine

A  Hypoglycemia

B  Edema

C  Heartburn

D  Seizures

A  Hyponatremia

B  Orthostatic hypotension

C  Hypokalemia

D  Hyperglycemia

A  Cyclosporine

B  Ciprofloxacin

C  Fludrocortisone

D  Glucocorticoids

A  Diabetes insipidus, Seizure, Type I von Willebrand

B  Cardiovascular disease, Diabetes insipidus, Type I von Willebrand

C  Asthma, Diabetes insipidus, Type I von Willebrand

D  Seizure, Asthma, Cardiovascular disease

A  Decreases fluid retention

B  Decreases growth

C  Reduces weight loss

D  Reduces fat levels

A  Low blood sugar levels, Retention of potassium levels, Increased retention of sodium

B  Low blood sugar levels, Increased lipid mobilization, Retention of potassium levels

C  Increased lipid mobilization, Increased retention of sodium, Improved tissue-building processes

D  Improved tissue-building processes, Low blood sugar levels, Retention of potassium levels

A  Thioridazine

B  Norepinephrine

C  Carbamazepine

D  Acetaminophen

A  Renal function studies, Liver enzyme levels, Blood pressure

B  Weight, Blood pressure, Blood glucose levels

C  Liver enzyme levels, Blood glucose levels, Renal function studies

D  Liver enzyme levels, Renal function studies, Weight

A  Constipation, Malaise, Hypercalciuria

B  Arthralgia, Hypercalciuria, Constipation

C  Malaise, Dyspnea,

D  Dyspnea, Constipation, Hypercalciuria

A  Hypotension

B  Scar formation

C  Edema

D  Inflammation

A  Reduces the effects of desmopressin

B  Causes prolongation of QT interval

C  Enhances the effects of desmopressin

D  Produces an additive effect

A  Somatropin

B  Desmopressin

C  Vasopressin

D  Octreotide

A  Octreotide

B  Desmopressin

C  Cosyntropin

D  Somatropin

A  Dehydration

B  Headache

C  Polyuria

D  Polydipsia

A  Oxytocin

B  Thyroid hormone

C  Cosyntropin

D  Octreotide

A  Carbamazepine

B  Cyclosporine

C  Ciprofloxacin

D  Demeclocycline

A  Uric acid level

B  Creatinine clearance test

C  Blood glucose level

D  Complete blood count result

A  Vasopressin

B  Desmopressin

C  Somatropin

D  Luteinizing hormone

A  Acromegaly

B  Polydipsia

C  Polyuria

D  Hypopituitary dwarfism

A  Oxytocin

B  Vasopressin

C  Cosyntropin

D  Octreotide

A  Somatropin

B  Somatolactin

C  Choriomammotropin

D  Somatostatin

A  Adrenocorticotropic hormone (ACTH), Aldosterone, Thyrotropin-releasing hormone (TRH)

B  Thyroxine, Aldosterone, Thyrotropin-releasing hormone (TRH)

C  Growth hormone (GH), Thyroid-stimulating hormone (TSH), Adrenocorticotropic hormone (ACTH)

D  Thyroxine, Thyroid-stimulating hormone (TSH), Thyrotropin-releasing hormone (TRH)

A  Relief of pain

B  Decreased adrenocorticotropic hormone levels

C  Increased urine specific gravity

D  Increased serum albumin levels